Table 2.
Vaccine preference, vaccine price per dose, cofinancing, and vaccine introduction year per country
| Vaccine preference | Vaccine price per dose (US$) | Average cofinancing per dose over 2018–27 period (US$) | Introduction year | |
|---|---|---|---|---|
| Afghanistan | Rotarix | 2·29 | 0·20 | 2018 |
| Angola | Rotarix | 2·29 | 2·29 | 2014 |
| Armenia | Rotarix | 2·29 | 2·29 | 2012 |
| Bolivia | Rotarix | 6·50 | 6·50 | 2008 |
| Burkina Faso | RotaTeq | 3·20 | 0·13 | 2013 |
| Burundi | Rotarix | 2·29 | 0·20 | 2013 |
| Cameroon | Rotarix | 2·29 | 0·90 | 2014 |
| Côte d'Ivoire | RotaTeq | 3·20 | 1·56 | 2017 |
| Djibouti | Rotarix | 2·29 | 0·53 | 2014 |
| Eritrea | Rotarix | 2·29 | 0·23 | 2014 |
| Ethiopia | Rotarix | 2·29 | 0·21 | 2013 |
| Georgia | Rotarix | 2·29 | 2·29 | 2013 |
| Ghana | Rotarix | 2·29 | 0·67 | 2012 |
| Guinea-Bissau | Rotarix | 2·29 | 0·20 | 2015 |
| Guyana | Rotarix | 6·50 | 6·50 | 2010 |
| Haiti | Rotarix | 6·50 | 0·20 | 2013 |
| Honduras | Rotarix | 6·50 | 6·50 | 2009 |
| India* | Rotavac/Rotasiil | 0·85/0·95 | 0·85/0·95 | 2017 |
| Kenya | Rotarix | 2·29 | 0·87 | 2014 |
| Kiribati | Rotarix | 6·20 | 6·20 | 2015 |
| Lesotho | Rotarix | 2·29 | 0·46 | 2017 |
| Liberia | Rotarix | 2·29 | 0·20 | 2016 |
| Madagascar | Rotarix | 2·29 | 0·20 | 2014 |
| Malawi | Rotarix | 2·29 | 0·20 | 2012 |
| Mali | RotaTeq | 3·20 | 0·13 | 2014 |
| Mauritania | Rotarix | 2·29 | 0·55 | 2014 |
| Moldova | Rotarix | 2·29 | 2·29 | 2012 |
| Mozambique | Rotarix | 2·29 | 0·20 | 2015 |
| Nicaragua | Rotarix | 6·50 | 5·98 | 2006 |
| Niger | Rotarix | 2·29 | 0·20 | 2014 |
| Pakistan | Rotarix | 2·29 | 1·25 | 2017 |
| Republic of Congo | Rotarix | 2·29 | 2·29 | 2014 |
| Rwanda | Rotarix | 2·29 | 0·20 | 2012 |
| São Tomé and Príncipe | RotaTeq | 3·20 | 2·36 | 2016 |
| Senegal | Rotarix | 2·29 | 0·20 | 2014 |
| Sierra Leone | Rotarix | 2·29 | 0·20 | 2014 |
| Sudan | Rotarix | 2·29 | 1·34 | 2011 |
| Tajikistan | Rotarix | 2·29 | 0·60 | 2015 |
| Tanzania | Rotarix | 2·29 | 0·20 | 2012 |
| The Gambia | Rotarix | 2·29 | 0·20 | 2013 |
| Togo | Rotarix | 2·29 | 0·20 | 2014 |
| Uganda | Rotarix | 2·29 | 0·20 | 2018 |
| Uzbekistan | Rotarix | 2·29 | 2·29 | 2014 |
| Yemen | Rotarix | 2·29 | 0·68 | 2012 |
| Zambia | Rotarix | 2·29 | 0·74 | 2013 |
| Zimbabwe | Rotarix | 2·29 | 0·20 | 2014 |
These data are for countries already using rotavirus vaccines at the end of 2018; countries not using rotavirus vaccines at the end of 2018 were randomly allocated one of the newly prequalified vaccines.
*
Assuming that 50% of immunised children are receiving Rotavac and the other 50% Rotasiil.